JP2009500423A5 - - Google Patents

Download PDF

Info

Publication number
JP2009500423A5
JP2009500423A5 JP2008520373A JP2008520373A JP2009500423A5 JP 2009500423 A5 JP2009500423 A5 JP 2009500423A5 JP 2008520373 A JP2008520373 A JP 2008520373A JP 2008520373 A JP2008520373 A JP 2008520373A JP 2009500423 A5 JP2009500423 A5 JP 2009500423A5
Authority
JP
Japan
Prior art keywords
compound
group
alkyl
compound according
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008520373A
Other languages
English (en)
Japanese (ja)
Other versions
JP5229897B2 (ja
JP2009500423A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/026258 external-priority patent/WO2007005991A1/en
Publication of JP2009500423A publication Critical patent/JP2009500423A/ja
Publication of JP2009500423A5 publication Critical patent/JP2009500423A5/ja
Application granted granted Critical
Publication of JP5229897B2 publication Critical patent/JP5229897B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008520373A 2005-07-05 2006-07-05 線維芽細胞活性化タンパクα阻害剤 Expired - Fee Related JP5229897B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69677205P 2005-07-05 2005-07-05
US60/696,772 2005-07-05
PCT/US2006/026258 WO2007005991A1 (en) 2005-07-05 2006-07-05 Inhibitors of fibroblast activation protein alpha

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012033777A Division JP2012140439A (ja) 2005-07-05 2012-02-20 線維芽細胞活性化タンパクα阻害剤

Publications (3)

Publication Number Publication Date
JP2009500423A JP2009500423A (ja) 2009-01-08
JP2009500423A5 true JP2009500423A5 (enExample) 2010-08-26
JP5229897B2 JP5229897B2 (ja) 2013-07-03

Family

ID=37604810

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008520373A Expired - Fee Related JP5229897B2 (ja) 2005-07-05 2006-07-05 線維芽細胞活性化タンパクα阻害剤
JP2012033777A Pending JP2012140439A (ja) 2005-07-05 2012-02-20 線維芽細胞活性化タンパクα阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012033777A Pending JP2012140439A (ja) 2005-07-05 2012-02-20 線維芽細胞活性化タンパクα阻害剤

Country Status (12)

Country Link
US (2) US7998997B2 (enExample)
EP (1) EP1898899A4 (enExample)
JP (2) JP5229897B2 (enExample)
KR (1) KR20080030079A (enExample)
CN (1) CN101247799B (enExample)
AU (1) AU2006264305B2 (enExample)
BR (1) BRPI0612607A2 (enExample)
CA (1) CA2613795A1 (enExample)
IL (2) IL188327A0 (enExample)
MX (1) MX2008000318A (enExample)
NO (1) NO20080626L (enExample)
WO (1) WO2007005991A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006246719A1 (en) * 2005-05-19 2006-11-23 Genentech, Inc. Fibroblast activation protein inhibitor compounds and methods
EP1760076A1 (en) * 2005-09-02 2007-03-07 Ferring B.V. FAP Inhibitors
MY161991A (en) 2007-08-06 2017-05-31 Millennium Pharm Inc Proteasome inhibitors
US7442830B1 (en) 2007-08-06 2008-10-28 Millenium Pharmaceuticals, Inc. Proteasome inhibitors
US7838673B2 (en) 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
JP5600595B2 (ja) * 2007-10-16 2014-10-01 ミレニアム ファーマシューティカルズ, インコーポレイテッド プロテアソーム阻害剤
DK2730581T3 (en) 2008-06-17 2016-08-15 Millennium Pharm Inc Boronate Ester Compounds and Pharmaceutical Compositions thereof.
AR075090A1 (es) 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
AU2011235227B2 (en) 2010-03-31 2016-09-08 Millennium Pharmaceuticals, Inc. Derivatives of 1-amino-2-cyclopropylethylboronic acid
JP6207509B2 (ja) * 2011-08-30 2017-10-04 トラスティーズ オブ タフツ カレッジ 固形腫瘍を治療するためのfap活性化プロテアソーム阻害剤
AU2012340887A1 (en) 2011-11-22 2014-07-03 Trustees Of Tufts College Small molecule enhancer for dendritic cell cancer vaccines
US20150202218A1 (en) * 2012-08-02 2015-07-23 Trustees Of Tufts College Broad Spectrum Inhibitors of the Post Proline Cleaving Enzymes for Treatment of Hepatitis C Virus Infections
AU2015264272A1 (en) 2014-05-20 2016-11-24 Millennium Pharmaceuticals, Inc. Boron-containing proteasome inhibitors for use after primary cancer therapy
CZ2014527A3 (cs) 2014-08-05 2016-02-17 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Způsob detekce aktivní formy analytů ve vzorku a stanovení schopnosti dalších látek vázat se do aktivních míst těchto analytů
MA41505A (fr) 2015-02-11 2017-12-19 Millennium Pharm Inc Nouvelle forme cristalline d'un inhibiteur de protéasome
WO2016171446A1 (ko) * 2015-04-20 2016-10-27 동아에스티 주식회사 펩타이드 붕소산 화합물을 함유하는 안정화 약학 제제
CN106588965A (zh) * 2015-10-15 2017-04-26 北京大学 脲拟肽硼酸化合物及其药物组合物、制备方法和用途
JP6223508B2 (ja) * 2016-06-27 2017-11-01 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. プロテアソーム阻害剤
US20200237936A1 (en) 2016-12-14 2020-07-30 Purdue Research Foundation Fibroblast activation protein (fap)-targeted imaging and therapy
US11613785B2 (en) 2017-01-09 2023-03-28 Onkosxcel Therapeutics, Llc Predictive and diagnostic methods for prostate cancer
CN108929340B (zh) * 2017-05-22 2019-12-13 北京大学 脯氨酸硼酸类化合物及其制备方法和用途
WO2019154859A1 (en) * 2018-02-06 2019-08-15 Universität Heidelberg Fap inhibitor
PE20230490A1 (es) 2020-03-24 2023-03-23 Tufts College Agentes para obtencion de imagenes y radiofarmacos dirigidos a la fap, y usos relacionados con los mismos
US20240207292A1 (en) * 2021-03-24 2024-06-27 Trustees Of Tufts College Boronic acid compounds, compositions and methods
CN118955616B (zh) * 2024-05-01 2025-09-02 杭州景嘉航生物医药科技有限公司 一种靶向结合成纤维细胞活化蛋白化合物及应用
CN119390720B (zh) * 2024-12-31 2025-04-01 杭州景嘉航生物医药科技有限公司 一种靶向结合成纤维细胞活化蛋白的双环[1.1.1]戊烷类化合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US497A (en) * 1837-12-01 Improvement in the machine for preparing ice for shipping and storing
US4935493A (en) * 1987-10-06 1990-06-19 E. I. Du Pont De Nemours And Company Protease inhibitors
US4963655A (en) 1988-05-27 1990-10-16 Mayo Foundation For Medical Education And Research Boron analogs of amino acid/peptide protease inhibitors
US5106948A (en) * 1988-05-27 1992-04-21 Mao Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US5159060A (en) * 1988-05-27 1992-10-27 Mayo Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
EP1463719A2 (en) * 2002-01-08 2004-10-06 Eisai Co., Ltd Eponemycin and epoxomicin analogs and uses thereof
EP2204181A3 (en) * 2002-04-30 2010-09-22 Trustees Of Tufts College Protease inhibitors
EP1578362A4 (en) 2002-07-09 2008-11-05 Point Therapeutics Inc COMBINATION THERAPY WITH A BOROPROLINE COMPOUND
EP1581496A4 (en) * 2002-12-02 2008-04-23 Gilead Sciences Inc 2-SUBSTITUTED 3-PROPENAMIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
US7576206B2 (en) * 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7674913B2 (en) 2003-11-12 2010-03-09 Phenomix Corporation Heterocyclic boronic acid compounds
AU2006246719A1 (en) * 2005-05-19 2006-11-23 Genentech, Inc. Fibroblast activation protein inhibitor compounds and methods

Similar Documents

Publication Publication Date Title
JP2009500423A5 (enExample)
JP2005539088A5 (enExample)
JP2006182786A5 (enExample)
JP2006143751A5 (enExample)
JP2005523922A5 (enExample)
JP2009502743A5 (enExample)
JP2010530372A5 (enExample)
JP2012502037A5 (enExample)
JP2002543185A5 (enExample)
JP2007302689A5 (enExample)
JP2010523692A5 (enExample)
JP2002332234A5 (enExample)
JP2007529532A5 (enExample)
JP2010536766A5 (enExample)
JP2010504908A5 (enExample)
JP2013507423A5 (enExample)
JP2007534702A5 (enExample)
JP2006515613A5 (enExample)
JP2008546770A5 (enExample)
JP2007535586A5 (enExample)
JP2010521516A5 (enExample)
JP2008534453A5 (enExample)
JP2014519507A5 (enExample)
JP2009520695A5 (enExample)
JP2003502367A5 (enExample)